久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

  Home>News Center>Life
         
 

Cheap AIDS pill as good as pricey brands
(Agencies)
Updated: 2004-07-03 10:21

A cheap three-in-one generic AIDS pill from India is just as good as more expensive branded medicines and should be widely used in developing countries, researchers said on Friday.

Lack of scientific evidence about the clinical effectiveness of such generic fixed-dose combinations has until now caused some international AIDS donors to refuse to fund their use.

But a team from the French national agency for AIDS research and Swiss charity Medecins sans Frontieres said Cipla's Triomune performed as well as brand drugs in the first open clinical study in a developing country.

They found that 80 percent of HIV-infected patients given the tablet twice a day had undetectable levels of virus in their blood after six months treatment.

Results of the study involving 60 patients in Cameroon, 92 percent of whom had full-blown AIDS, were published in The Lancet medical journal.

“This generic fixed-dose combination (FDC) gives results comparable to those seen in the developed world using triple-drug therapy comprising brand name drugs,” said study co-ordinator Eric Delaporte.

“It is now no longer possible to raise scientific uncertainty as an objection to the widespread utilization of FDCs in the developing countries.”

In addition to being cheaper, drugs like Triomune -- which contains GlaxoSmithKline's lamivudine, Bristol-Myers Squibb's stavudine and Boehringer Ingelheim's nevirapine -- are simpler to use since patients need to take only two pills a day.

As such, they have a major role to play in meeting the World Health Organization's goal of getting antiretrovirals to three million people in the developing world by the end of 2005, N. Kumarasamy of the YRG Centre for AIDS Research and Education in Madras wrote in a commentary accompanying the research.

Controversy remains

The WHO has judged Triomune and another Indian combination called Triviro, from Ranbaxy Laboratories, to be safe and effective under a scheme that “prequalifies” them for use.

But both products -- which use compounds still covered by patents -- remain controversial.

Washington has barred groups receiving U.S. government funds from buying them, insisting only drugs approved by the Food and Drug Administration be used.

U.S. officials and Western pharmaceutical executives argue health providers are taking a risk by using medicines which have not passed the rigorous standards of the U.S. drugs watchdog.

Worries about the quality of Indian medicines were fuelled last month when the WHO removed two Cipla products -- though not Triomune -- from its prequalification list because they had not been proven to be equivalent to the original products.

Cipla says it is collecting data from new studies which should lead to the drugs being re-instated.

In Cameroon, where drugs are subsidized by the government, the cost of one month’s Triomune is $20, compared to $35 for the equivalent brand name therapy, even after heavy discounting by big pharmaceutical companies.

Elsewhere, cost differences can vary by as much as 100 percent, according to Medecins sans Frontieres.



Jackie Chan's new film 'The Myth'
CK over the top
Stephen Chow's kong fu to hit Mainland cinemas
  Today's Top News     Top Life News
 

Stress kills workaholic academics at young age

 

   
 

Efforts urged to curb floods, drought

 

   
 

China opposes foreign interference in HK

 

   
 

Ministry battles telecom price wars

 

   
 

UK indicts three in shell-fish drownings

 

   
 

Migrant workers given classes on AIDS

 

   
  Marlon Brando dies in Los Angeles hospital
   
  Apple plans new iMac, but delays shipment until Sept
   
  Fragrance makers hook up with Hollywood stars
   
  Piano maker tunes into China's growing middle class
   
  Nation hurries to salvage undersea cultural relics
   
  Panda smokes draw a crowd
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Feature  
  Oops! Britney to do marriage again  
Advertisement
         
主站蜘蛛池模板: 亚洲精品国产综合久久一线 | 久久亚洲国产伦理 | 欧美精品网站 | 自拍一区在线观看 | 成年女人在线视频 | 日韩经典一区 | 日本久久综合 | 草草影院ccyycom浮力影院 | 中文乱码一二三四有限公司 | 中文字幕在线观看国产 | 色视频网站大全免费 | 九九精品视频在线播放 | 美女黄色影院 | 99九九精品视频 | 国产人成亚洲第一网站在线播放 | 国产精品爱久久久久久久小 | 免费国产一区二区在免费观看 | 欧美三级成人观看 | 日本免费人做人一区在线观看 | 99久久精品久久久久久清纯 | 国内外成人免费视频 | 久草免费在线播放视频 | 一级a毛片免费观看久久精品 | 国产一级特黄aaa大片 | 国产成人教育视频在线观看 | 国内自拍一区 | 精品国产综合区久久久久久 | av片免费大全在线观看不卡 | 深夜福利国产福利视频 | 久久93精品国产91久久综合 | 国产精品国产三级国产在线观看 | 在线观看日本免费视频大片一区 | 2020精品极品国产色在线观看 | 欧美jizzhd精品欧美高清 | 久久综合狠狠综合狠狠 | 亚洲日本综合 | 国产精品久久久久久久久久影院 | 欧美中文字幕在线看 | www.亚洲视频 | 日本亚洲视频 | 在线视频 亚洲 |